Discovering and developing innovative therapeutics for CNS disorders

Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SIX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.

Latest Press Releases

Newron Announces change in Management

14/05/2012
English ENG  German GER

Newron Reports Completion of Phase III program for Safinamide in early and advanced Parkinsons disease patients

14/05/2012
English ENG  German GER

Investor News

Please click here to view Newron share price information on SIX.